beta(3)-Adrenergic receptor-mediated lipolysis and oxygen consumption in brown adipocytes from cynomolgus monkeys

被引:24
作者
Meyers, DS [1 ]
Skwish, S [1 ]
Dickinson, KEJ [1 ]
Kienzle, B [1 ]
Arbeeny, CM [1 ]
机构
[1] BRISTOL MYERS SQUIBB PHARMACEUT RES INST, PRINCETON, NJ 08543 USA
关键词
D O I
10.1210/jc.82.2.395
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Primary adipocytes were isolated from axillary brown adipose tissue from adult cynomolgus monkeys. That this tissue contained brown adipocytes was verified by morphological examination and by demonstrating the presence of uncoupling protein messenger ribonucleic acid in the isolated adipocytes. The contributions of beta(1)-, beta(2)-, and beta(3)-adrenergic receptors (AR) to lipolysis and oxygen consumption of isolated brown adipocytes were determined after agonist stimulation. Dose responses were determined using isoproterenol (a nonselective P-AR agonist), denopamine (Beta(1)-AR agonist), procaterol (beta(2)-AR agonist), and CGP12177A (beta(1)- and beta(2)-AR antagonist, beta(3)-AR agonist). Isoproterenol, denopamine, and procaterol stimulated lipolysis with EC(50) values of 4,500, and 83 nmol/L, respectively. Intrinsic activities (relative to isoproterenol maxima) were 100%, 74%, and 59%, respectively. The presence of beta(3)-ARs coupled to lipolysis was demonstrated by the activity of CGP12177A (EC(50) = 1.6 mu mol/L; intrinsic activity = 62%). Isoproterenol stimulated oxygen consumption of brown adipocytes by 75-100% above the basal rate, with an EC(50) of 1 mu mol/L. Denopamine, procaterol, and CGP12177A stimulated oxygen consumption at a concentration of 100 mu mol/L. These results demonstrate that all three beta-adrenergic receptor subtypes are coupled to lipolysis and oxygen consumption in brown adipocytes from cynomolgus monkeys.
引用
收藏
页码:395 / 401
页数:7
相关论文
共 31 条
[1]  
ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
[2]   BETA-ADRENERGIC CONTROL OF LIPOLYSIS IN PRIMATE WHITE FAT-CELLS - A COMPARATIVE-STUDY WITH NONPRIMATE MAMMALS [J].
BOUSQUETMELOU, A ;
GALITZKY, J ;
CARPENE, C ;
LAFONTAN, M ;
BERLAN, M .
AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 267 (01) :R115-R123
[3]  
BOUSQUETMELOU A, 1995, J LIPID RES, V36, P451
[4]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[5]   SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION [J].
CHOMCZYNSKI, P ;
SACCHI, N .
ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) :156-159
[6]   PEPTIDASES AND SMOOTH-MUSCLE CELL ANGIOTENSIN-II RECEPTOR PHARMACOLOGY [J].
COHEN, RB ;
WEBB, ML ;
DICKINSON, KEJ .
PEPTIDES, 1993, 14 (02) :345-352
[7]   IMPAIRED EXPRESSION AND FUNCTIONAL-ACTIVITY OF THE BETA(3)-ADRENERGIC AND BETA(1)-ADRENERGIC RECEPTORS IN ADIPOSE-TISSUE OF CONGENITALLY OBESE (C57BL/6J OB/OB) MICE [J].
COLLINS, S ;
DANIEL, KW ;
ROHLFS, EM ;
RAMKUMAR, V ;
TAYLOR, IL ;
GETTYS, TW .
MOLECULAR ENDOCRINOLOGY, 1994, 8 (04) :518-527
[8]   MOLECULAR CHARACTERIZATION OF THE HUMAN BETA-3-ADRENERGIC RECEPTOR [J].
EMORINE, LJ ;
MARULLO, S ;
BRIENDSUTREN, MM ;
PATEY, G ;
TATE, K ;
DELAVIERKLUTCHKO, C ;
STROSBERG, AD .
SCIENCE, 1989, 245 (4922) :1118-1121
[9]   DEMONSTRATION OF AN IN-VIVO FUNCTIONAL BETA(3)-ADRENOCEPTOR IN MAN [J].
ENOCKSSON, S ;
SHIMIZU, M ;
LONNQVIST, F ;
NORDENSTROM, J ;
ARNER, P .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (05) :2239-2245
[10]  
Grant T. L., 1994, British Journal of Pharmacology, V112, p213P